Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nephrogenic systemic fibrosis: an update.

Shawn E Cowper1, Philip J Boyer

  • 1Yale University, Department of Dermatology, New Haven, CT 06520-8059, USA. shawn.cowper@yale.edu

Current Rheumatology Reports
|March 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epithelioid Fibrous Histiocytoma Involving Deep Dermis and Subcutaneous Adipose Tissue.

Journal of cutaneous pathology·2026
Same author

Novel RNF113A Variant Underlying X-Linked Trichothiodystrophy With Presumed Mosaicism in an Unaffected Mother.

American journal of medical genetics. Part A·2026
Same author

Leveraging Interpretable AI for Deciphering Signature Histopathologic Patterns.

Journal of cutaneous pathology·2026
Same author

Brown patches and erosions with an erythematous base.

JAAD case reports·2025
Same author

Part II. Dermatologic Manifestations Associated with Treatment of Patients with Kidney Disease.

Journal of the American Academy of Dermatology·2025
Same author

Part I. Dermatologic Manifestations in Patients with Kidney Disease.

Journal of the American Academy of Dermatology·2025
Same journal

Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.

Current rheumatology reports·2026
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
See all related articles

Nephrogenic systemic fibrosis (NSF) is a serious condition linked to kidney problems. Research suggests it may involve bone marrow cells being improperly directed to the skin, possibly due to blood vessel damage.

Area of Science:

  • Rheumatology
  • Nephrology
  • Dermatology

Background:

  • Nephrogenic systemic fibrosis (NSF), formerly nephrogenic fibrosing dermopathy, is an emerging systemic fibrosing disorder.
  • NSF is specifically associated with patients experiencing renal insufficiency.
  • The incidence and recognition of NSF have increased globally since 1997.

Purpose of the Study:

  • To highlight the importance of rheumatologists recognizing NSF symptoms and comorbidities.
  • To emphasize the need for prompt work-up and treatment initiation by rheumatology professionals.
  • To present a novel model for the pathogenesis of NSF.

Main Methods:

  • Review of existing literature and case reports on NSF.
  • Analysis of clinical presentations and associations of NSF.

Related Experiment Videos

  • Formulation of a pathogenetic model based on current research.

    • Main Results:

    • NSF is increasingly reported in rheumatology literature, indicating rising prevalence.
    • Rheumatology professionals are often the first point of contact for new NSF cases.
    • A new model proposes aberrant recruitment of fibrocytes to systemic sites, potentially triggered by endothelial damage.

    Conclusions:

    • Early recognition and management of NSF by rheumatologists are crucial.
    • Understanding the underlying mechanisms of NSF is essential for effective treatment.
    • The proposed model offers a framework for future research into NSF etiology.